About Certis Oncology Solutions
Certis Oncology Solutions is a company based in San Diego (United States) founded in 2016 by James H Berglund.. Certis Oncology Solutions has raised $13.65 million across 2 funding rounds. Certis Oncology Solutions offers products and services including CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology. Certis Oncology Solutions operates in a competitive market with competitors including Xentech, Nanoligent and Rincon Bio, among others.
- Headquarter San Diego, United States
- Founders James H Berglund
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Certis Oncology Solutions, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.65 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Series C
Jan 17, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Certis Oncology Solutions
Certis Oncology Solutions offers a comprehensive portfolio of products and services, including CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for oncology intelligence and data analysis in research
Custom development of cancer models for testing and pharmacology
Pharmacology testing for drug development in oncology studies
In vivo testing methods for cancer research and endpoint analysis
Unlock access to complete
Unlock access to complete
Funding Insights of Certis Oncology Solutions
Certis Oncology Solutions has successfully raised a total of $13.65M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $10.0M
-
First Round
First Round
(03 Nov 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series C - Certis Oncology Solutions | Valuation |
investors |
|
| Nov, 2023 | Amount | Series A - Certis Oncology Solutions | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Certis Oncology Solutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Certis Oncology Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Certis Oncology Solutions Comparisons
Competitors of Certis Oncology Solutions
Certis Oncology Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xentech, Nanoligent and Rincon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient-derived xenograft models for preclinical oncology research are provided.
|
|
| domain | founded_year | HQ Location |
Preclinical services for oncology drug development are provided.
|
|
| domain | founded_year | HQ Location |
Pre-clinical CRO for in vivo cancer efficacy studies using xenograft and syngeneic models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Certis Oncology Solutions
Frequently Asked Questions about Certis Oncology Solutions
When was Certis Oncology Solutions founded?
Certis Oncology Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Where is Certis Oncology Solutions located?
Certis Oncology Solutions is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Certis Oncology Solutions a funded company?
Certis Oncology Solutions is a funded company, having raised a total of $13.65M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.65M, raised on Nov 03, 2023.
What does Certis Oncology Solutions do?
Certis Oncology Solutions was founded in 2016 and is based in San Diego, United States. In-vivo services focused on oncology are offered to pharmaceutical and biotechnology companies. Certis Orthotopic PDX techniques, involving patient-derived orthotopic xenografts, are utilized to model human tumor growth, metastasis, and therapy responses. These services support drug development in the oncology sector.
Who are the top competitors of Certis Oncology Solutions?
Certis Oncology Solutions's top competitors include Nanoligent, Xentech and Rincon Bio.
What products or services does Certis Oncology Solutions offer?
Certis Oncology Solutions offers CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology.